NRXP

Nrx Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↓ 4/10
  • Value↓ 0/10
Nrx Pharmaceuticals sales and earnings growth
NRXP Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -10.28%
  • FCF Y/Y↓ -6.54%
Nrx Pharmaceuticals gross and profit margin trends
NRXP Profitability
Good
  • Gross margin ↑ 59.90%
  • EPS margin↓ -15727.70%
  • ROIC 5Y↑ 829.81%
Nrx Pharmaceuticals net debt vs free cash flow
NRXP Risk
Poor
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 0.3
  • Interest coverage↑ 999.0

Nrx Pharmaceuticals stock volatility is in-line with the overall market. We give it a Poor risk rating.

More Biotechnology stocks ↗